Back to Journals Clinical, Cosmetic and Investigational Dermatology Volume 15 Coexistence of Riehls Melanosis, Lupus Erythematosus and Thyroiditis in a Patient Authors Lai K , Zheng X, Wei S, Zhou H, Zeng X, Liang G, Zhang Z, Zhang W Received 29 May 2022 Accepted for publication 19 August 2022 Published 8 September 2022 Volume 2022:15 Pages 18091813 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Jeffrey Weinberg Kuan Lai, 1 Xinyao Zheng, 1 Shanshan Wei, 2 Huifeng Zhou, 1 Xuedan Zeng, 1 Guixin Liang, 1 Zhiwen Zhang, 1 Wenjing Zhang 3 1 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, Peoples Republic of China

Post hoc analyses of the comparisons among the treatment groups for coronary revascularizations demonstrated an HR of 0.76 (95% CI, 0.491.17), including 0.67 (95% CI, 0.401.13) for urgent revascularizations and 0.77 (95% CI, 0.371.61) for non-urgent revascularizations
It provides a more stable, sustained presence of the peptide in the bloodstream rather than a rapid peak and fall, potentially allowing for a more prolonged therapeutic window
It will not ruin the entire 12 weeks
Key Takeaways Significant Improvement in Walking Ability: The trial demonstrated that Semaglutide provides a direct and meaningful benefit for mobility